— Know what they know.
Not Investment Advice

NBIO OTC

Nascent Biotech, Inc.
1W: +0.0% 1M: -33.3% 3M: -60.0% YTD: -66.7% 1Y: -97.1% 3Y: -99.7% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 45 · $34443 mcap · 99M float · 0.027% daily turnover · Short 80% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-2M
Net Income
+5.7% YoY
$-1M
Free Cash Flow
+16.1% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE230.6%
ROA-1256.8%
ROIC328.8%

Valuation

P/E-0.0
P/B-0.1
EV/EBITDA-7.8

Leverage

Debt/Equity-0.11
Current Ratio0.31
Interest Cov.-13.1x

Quality Scores

Piotroski F5/9
Altman Z-170.53
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms